Digital Platform for Remote Monitoring of COPD After Bronchoscopic Lung Volume Reduction

Overview

About this study

The purpose of this study is to determine if remote monitoring using the appropriate platform can improve the management of COPD patients after bronchoscopic lung volume reduction.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • 18 years of age or older.
  • Diagnosis of COPD.
  • Selected to receive bronchoscopic lung volume reduction procedure.
  • Willingness to wear a remote monitoring device for the length of the trial.

Exclusion Criteria: 

  • Unable or unwilling to signed informed consent form.
  • Prior lung transplant, LVRS, median sternotomy, or lobectomy.
  • Significant abnormalities like musculoskeletal or cardiac pathologies that disturbs the walking abilities.
  • Patients with cardiac pacemaker, defibrillators, or other implanted electronic devices.
  • Inability to complete bronchoscopic lung volume reduction procedure.

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Eligibility last updated 1/25/24. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Megan Dulohery Scrodin, M.D.

Contact us for the latest status

Contact information:

Kayla Quinn M.S., CCRP

(507) 538-0595

Quinn.Kayla2@mayo.edu

More information

Publications

Publications are currently not available